Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Rheumatology (Oxford)
Published November 13, 2026
Urinary β2-microglobulin as a prognostic and treatment-associated biomarker in anti-MDA5 antibody...
November 13, 2026
Medspoke
Medspoke
Rheumatology (Oxford)
Published November 13, 2026
00:00
--:--
Herpes zoster in rheumatoid arthritis and in relation to biologic/targeted synthetic disease modi...
November 13, 2026
Share
Herpes zoster in rheumatoid arthritis and in relation to biologic/targeted synthetic disease modifying anti-rheumatic drugs: a Swedish national study.
https://www.medspoke.co/channel_journal?id=688&tap_id=17570
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Rheumatology (Oxford)
Published November 13, 2026
Long-term efficacy and safety of upadacitinib in patients with polyarticular-course juvenile idio...
November 13, 2026
Why are you reporting this TALK?